Form 8.3 - HORIZON THERAPEUTICS PLC

Barclays PLC

15 June 2023

 

FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1.				KEY INFORMATION
Name of person dealing (Note 1)				Barclays PLC.
Company dealt in				HORIZON THERAPEUTICS PLC
Class of relevant security to which the dealings being disclosed relate (Note 2)				$0.001 ordinary shares
Date of dealing				14 Jun 2023
2.				INTERESTS AND SHORT POSITIONS
(a)	Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security:				$0.001 ordinary shares
				Long		Short
				Number	(%)	Number	(%)
(1)	Relevant securities			1,012,362	0.44%	698,966	0.31%
(2)	Derivatives (other than options):			140,756	0.06%	98,064	0.04%
(3)	Options and agreements to purchase/sell:			1,404,500	0.61%	961,400	0.42%
TOTAL:				2,557,618	1.12%	1,758,430	0.77%
(b)	Interests and short positions in relevant securities of the company, other than the class dealt in
Class of relevant security:				Long		Short
				Number	(%)	Number	(%)
(1)	Relevant securities
(2)	Derivatives (other than options):
(3)	Options and agreements to purchase/sell:
TOTAL:
3.				DEALINGS (Note 4)
(a)	Purchase and sales
Class of relevant Security			Purchase/sale			Number of securities	Price per unit
$0.001 ordinary shares			Purchase			12	100.0600 USD
$0.001 ordinary shares			Purchase			79	100.1867 USD
$0.001 ordinary shares			Purchase			93	100.0441 USD
$0.001 ordinary shares			Purchase			100	100.2505 USD
$0.001 ordinary shares			Purchase			100	100.2750 USD
$0.001 ordinary shares			Purchase			124	99.9300 USD
$0.001 ordinary shares			Purchase			200	100.2200 USD
$0.001 ordinary shares			Purchase			250	100.0244 USD
$0.001 ordinary shares			Purchase			313	100.1811 USD
$0.001 ordinary shares			Purchase			314	100.1230 USD
$0.001 ordinary shares			Purchase			333	100.1355 USD
$0.001 ordinary shares			Purchase			367	100.1213 USD
$0.001 ordinary shares			Purchase			507	100.2353 USD
$0.001 ordinary shares			Purchase			1,123	100.1494 USD
$0.001 ordinary shares			Purchase			2,645	100.2331 USD
$0.001 ordinary shares			Purchase			3,040	100.2420 USD
$0.001 ordinary shares			Purchase			4,698	100.6014 USD
$0.001 ordinary shares			Purchase			7,625	100.2373 USD
$0.001 ordinary shares			Purchase			7,982	100.4003 USD
$0.001 ordinary shares			Purchase			8,828	100.2176 USD
$0.001 ordinary shares			Purchase			9,865	100.0264 USD
$0.001 ordinary shares			Purchase			11,739	100.6200 USD
$0.001 ordinary shares			Purchase			21,159	100.5511 USD
$0.001 ordinary shares			Purchase			33,347	100.4098 USD
$0.001 ordinary shares			Sale			1	100.3200 USD
$0.001 ordinary shares			Sale			1	100.1700 USD
$0.001 ordinary shares			Sale			2	100.1150 USD
$0.001 ordinary shares			Sale			12	100.1891 USD
$0.001 ordinary shares			Sale			12	100.1462 USD
$0.001 ordinary shares			Sale			12	100.2116 USD
$0.001 ordinary shares			Sale			24	99.9300 USD
$0.001 ordinary shares			Sale			60	100.2960 USD
$0.001 ordinary shares			Sale			72	100.2745 USD
$0.001 ordinary shares			Sale			76	100.4285 USD
$0.001 ordinary shares			Sale			79	100.2235 USD
$0.001 ordinary shares			Sale			79	100.1867 USD
$0.001 ordinary shares			Sale			100	99.9500 USD
$0.001 ordinary shares			Sale			100	100.2000 USD
$0.001 ordinary shares			Sale			100	100.0200 USD
$0.001 ordinary shares			Sale			100	100.3700 USD
$0.001 ordinary shares			Sale			100	99.9100 USD
$0.001 ordinary shares			Sale			115	100.2064 USD
$0.001 ordinary shares			Sale			129	100.4900 USD
$0.001 ordinary shares			Sale			150	100.2466 USD
$0.001 ordinary shares			Sale			150	100.1166 USD
$0.001 ordinary shares			Sale			183	100.0000 USD
$0.001 ordinary shares			Sale			200	100.2400 USD
$0.001 ordinary shares			Sale			200	100.0650 USD
$0.001 ordinary shares			Sale			397	100.1010 USD
$0.001 ordinary shares			Sale			517	100.0241 USD
$0.001 ordinary shares			Sale			598	99.9858 USD
$0.001 ordinary shares			Sale			900	99.9905 USD
$0.001 ordinary shares			Sale			900	100.5244 USD
$0.001 ordinary shares			Sale			997	100.3233 USD
$0.001 ordinary shares			Sale			1,000	100.0135 USD
$0.001 ordinary shares			Sale			1,226	100.4003 USD
$0.001 ordinary shares			Sale			1,509	99.9944 USD
$0.001 ordinary shares			Sale			1,525	100.1019 USD
$0.001 ordinary shares			Sale			1,702	99.9527 USD
$0.001 ordinary shares			Sale			2,000	99.9992 USD
$0.001 ordinary shares			Sale			2,244	100.0771 USD
$0.001 ordinary shares			Sale			3,245	100.2558 USD
$0.001 ordinary shares			Sale			3,480	100.2838 USD
$0.001 ordinary shares			Sale			4,557	100.2553 USD
$0.001 ordinary shares			Sale			5,944	100.4256 USD
$0.001 ordinary shares			Sale			6,175	100.6200 USD
$0.001 ordinary shares			Sale			23,978	100.4961 USD
$0.001 ordinary shares			Sale			39,893	100.3808 USD
(b)	Derivatives transactions (other than option transactions)
Product Name		Nature of transaction				Number of relevant securities	Price per unit
(c)	Options transactions in respect of existing securities
(i)	Writing, selling, purchasing or varying
Class  of  relevant  security	Product  description	Writing,  purchasing,  selling,  varying etc	Number  of  securities  to which  option  relates	Exercise  price  per unit	Type	Expiry  date	Option  money  paid/  received  per unit
(ii)	Exercising
Product name			Number of  securities			Exercise price  per unit
(d)	Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction				Details		Price per unit  (if applicable)
4.				OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing  and any other person relating to the voting rights of any relevant securities under any option  referred to on this form or relating to the voting rights or future acquisition or disposal of any  relevant securities to which any derivative referred to on this form is referenced. If none, this  should be stated.
NONE
Is a Supplemental Form 8 (Open Positions) attached?				YES
Date of disclosure:				15 Jun 2023
Contact name:				Large Holdings Regulatory Operations
Telephone number:				020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL
ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as
appropriate)
OPEN POSITIONS
Class of relevant  security		Product  Description	Writing,  purchasing,  selling,  varying etc	Number  of  securities  to which  option  relates	Exercise  price  per unit	Type	Expiry  date
$0.001 ordinary shares		Put Options	Written	495,500	100	American	16 Jun 2023
$0.001 ordinary shares		Call Options	Written	-25,000	115	American	18 Aug 2023
$0.001 ordinary shares		Put Options	Written	28,800	095	American	21 Jul 2023
$0.001 ordinary shares		Call Options	Written	-10,600	105	American	18 Aug 2023
$0.001 ordinary shares		Put Options	Written	2,000	085	American	21 Jul 2023
$0.001 ordinary shares		Put Options	Purchased	-250,000	080	American	16 Jun 2023
$0.001 ordinary shares		Put Options	Written	10,200	080	American	18 Aug 2023
$0.001 ordinary shares		Put Options	Written	232,000	105	American	16 Jun 2023
$0.001 ordinary shares		Call Options	Written	-2,600	100	American	18 Aug 2023
$0.001 ordinary shares		Call Options	Written	-2,000	100	American	21 Jul 2023
$0.001 ordinary shares		Put Options	Written	400,000	100	American	18 Aug 2023
$0.001 ordinary shares		Put Options	Written	74,000	090	American	15 Sep 2023
$0.001 ordinary shares		Put Options	Purchased	-544,200	080	American	18 Aug 2023
$0.001 ordinary shares		Put Options	Written	162,000	105	American	21 Jul 2023
$0.001 ordinary shares		Call Options	Written	-10,000	105	American	16 Jun 2023
$0.001 ordinary shares		Put Options	Purchased	-10,200	100	American	18 Aug 2023
$0.001 ordinary shares		Put Options	Purchased	-106,800	090	American	21 Jul 2023

 

END